Memorial Sloan Kettering Cancer Center: Rectal Neoplasms trials

The registry lists 25 Rectal Neoplasms studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 6 are open to participants now and 6 have results posted.

Phase 2 10Phase 3 3No phase 13(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal CancerNot yet recruitingNCT07691489Phase 2
• A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and ChemotherapyRecruitingNCT07227636Phase 2
• A Study of Response to Standard Treatment Before Surgery in People With Rectal CancerRecruitingNCT06637462Not applicable
• A Study of Tucatinib and Trastuzumab in People With Rectal CancerRecruitingNCT05672524Phase 2
• Biopsy After Radioembolization to Identify Changes in Tumor Cells From the RadiationRecruitingNCT04668872
• Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid TumorsRecruitingNCT04165772Phase 2
• Sacral Neuromodulation (SNM) With InterStimTM for Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter PreservationTerminatedNCT02163187Phase 2/3Results posted
• Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal CancerCompletedNCT01345175Phase 3Results posted
• Clinical and Translational Study of STA-9090CompletedNCT01111838Phase 2Results posted
• The Sexual Health of Rectal Cancer PatientsCompletedNCT00712751Results posted
• Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain MetastasesCompletedNCT00587964Phase 2Results posted
• Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal CancerCompletedNCT00462501Not applicableResults posted
• Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative ManagementActive, not recruitingNCT02008656Phase 2
• Advanced MR Imaging for Early Biologic Tumor Changes to Neoadjuvant Chemoradiation Treatment for Rectal CancerCompletedNCT01830582Not applicable
• Feasibility and Psychometric Properties of Paper vs. Web vs. Automated Telephone Administration of Patient Reported Outcome SurveysCompletedNCT01458509
• Characterization of Rectal Cancer Hypoxia Using pO2 Histography and Immunohistochemistry for Hypoxia-Related ProteinsCompletedNCT01189877Not applicable
• Genomic Structural Variation in Cancer SusceptibilityActive, not recruitingNCT00996710
• Evaluating The Response to Pre-Operative Chemotherapy and/or Radiation Therapy For Rectal Cancer Using Three-Dimension Transrectal UltrasoundCompletedNCT00597610Not applicable
• Functional Outcomes and Quality of Life in Patients Undergoing Surgery for Rectal CancerCompletedNCT00579579
• Magnetic Resonance Study of Liver in ChemotherapyCompletedNCT00578838
• Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the LiverActive, not recruitingNCT00492999Phase 2
• Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal CancerActive, not recruitingNCT00335816Phase 2
• Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal CancerCompletedNCT00102011Phase 3
• Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal CancerCompletedNCT00084773Not applicable
• PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During SurgeryCompletedNCT00004891Not applicable